241Am removal by DTPA vs. occurrence of skeletal malignancy.

Abstract

Beagle dogs injected with 241Am and treated subsequently with DTPA exhibited a reduced occurrence of skeletal malignancies and increased lifespans when compared to corresponding untreated animals also given 241Am. Whereas 92% of dogs given about 11 kBq 241Am kg(-1) and not treated with DTPA developed bone cancer (skeletal dose about 5.9 Gy), skeletal… (More)

Topics

Cite this paper

@article{Lloyd1998241AmRB, title={241Am removal by DTPA vs. occurrence of skeletal malignancy.}, author={Robert Lloyd and G. N. Taylor and Christopher Mays}, journal={Health physics}, year={1998}, volume={75 6}, pages={640-5} }